Vaccine,Commerical Name,Manufacturer,Year First Licensed (Country/Region),Serotypes Covered,Reference #
V116,CAPVAXIVE,Merck,2024 (USA),"3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15C, 16F, 17F, 19A, 20, 22F, 23A, 23B, 24F, 31, 33F, 35B",30
PCV20,Prevnar20,Pfizer,2021 (USA),"1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A , 19F, 22F, 23F, 33F",31
PCV15,Vaxneuvance,Merck,2021 (USA),"1, 3, 4, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, 33F",31
PCV10,Pneumosil,Serum Institute of India,2020 (India),"1, 5, 6A, 6B, 7F, 9V, 14, 19A, 19F, 23F",32
PCV13,Prevnar13,Pfizer,2010 (USA),"1, 3, 4, 5, 6A, 6B 7F, 9V, 14, 18C, 19A, 19F, 23F            ",31
PCV10,Synflorix,GSK,2009 (EU),"1, 4, 5, 6B 7F, 9V, 14, 18C, 19F, 23F     ",33
PCV7,Prevnar,Pfizer,2000 (USA),"4, 6B, 9V, 14, 18C, 19F, 23F",31
PPV23 or PPSV23,Pneumovax23,Merck,1984 (USA),"1, 2, 3, 4, 5, 6B, 7F, 8, 9V, 9N, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F, 33F",31